Poly(vinyl alcohol), PVA, is the most frequently used material in embolization of tumors, aneurisms and arteriovenous malformations due to its low toxicity, good biocompatibility and desirable physical properties. It is well known that PVA particles cannot be prepared by direct polymerization of vinyl alcohol. Its synthesis is typically performed by the suspension polymerization of vinyl acetate to produce poly(vinyl acetate), PVAc, followed by the saponification of the PVAc particles. This work shows that, using the suspension polymerization technique, it is possible to obtain spherical particles with a core‐shell structure of PVA/PVAc with regular morphology, instead of particles with irregular shapes and sizes, as usually found in many commercial embolization products. Therefore, this work presents the production of PVA/PVAc spherical particles that can be used to occlude blood vessels, eliminating the disadvantages of commercial PVA. In vivo clinical tests with white “New Zealand” rabbits undergoing kidney inflammation reaction have shown that these spherical particles are much more efficient for vascular embolization.
Embolization is a radiological technique that consists in occluding a blood vessel intentionally with an embolic agent (particle). A suspension polymerization process was developed to allow for production of embolic particles with core‐shell morphology. This technology was modified to allow for the in‐situ incorporation of antibiotics (amoxicillin) in PVA/PVAc‐co‐PMMA core‐shell particles. The incorporation of amoxicillin led to modification of some of the final polymer properties, including the particle morphology, the molecular weight distribution and the characteristic transition temperatures of the polymer material. The final polymer properties depended on the antibiotic concentration and on how the drug was added into the polymerization medium.
Stochastic modeling constitutes a powerful technique to obtain complete distributions of microstructural properties of polymer materials and may help to synthesize polymers with well-defined microstructure, as in the case of controlled radical polymerizations (CRP). However, these techniques have been often applied to describe polymerizations performed in batch or idealized continuous plug flow conditions. The present manuscript describes a Monte Carlo technique that can be used to calculate microstructural properties in polymerization systems performed continuously with arbitrary residence time distributions (RTD), under regime of complete micromixing segregation. The technique approximates the continuous system by a set of batch reactors, operated independently, whose volumes and batch times can be related to the discretized version of the RTD. The technique is applied successfully to describe a styrene-based CRP reaction carried out in an ideal continuous stirred tank reactor and a tubular non-ideal tubular reactor.
An improvement to a previously published suspension polymerization process for the production of spherical core/shell PVAc/PVA particles is described. To increase the settling time of the beads in the suspension, an expansion stage was introduced. The core/shell structure was obtained through the partial hydrolysis of the PVAc. The particle density was manipulated through addition of a solvent during the suspension polymerization stage and posterior expansion of the polymer beads obtained at the end of the process. This technique allows for effective reduction of the density of the final polymer beads. The expansion stage exerts also a beneficial effect on particle drying, avoiding particle aggregation during post‐polymerization processing of the polymer beads.magnified image
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.